A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1994
10/31/1994	CA2122531A1 Anionic polymerization initiators and reduced hysteresis products therefrom
10/29/1994	CA2121990A1 Antibody-drug conjugates
10/27/1994	WO1994024564A1 Methods for diabetes susceptibility assessment in asymptomatic patients
10/27/1994	WO1994024304A1 Rapamycin assay
10/27/1994	WO1994024297A1 Defective recombinant adenoviruses for gene therapy of tumours
10/27/1994	WO1994024296A2 Recombinant bovine herpesvirus type 1 vaccines
10/27/1994	WO1994024291A2 Compositions of antigen containing recombinant salmonella, their use in anti-malarial vaccines and method for their preparation
10/27/1994	WO1994024290A1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin
10/27/1994	WO1994024287A1 Gene encoding the lactate dehydrogenase enzyme of plasmodium falciparum
10/27/1994	WO1994024280A1 Expression of beta-2-microglobulin in pichia pastoris
10/27/1994	WO1994024275A1 Model for gonococcal infection
10/27/1994	WO1994024268A1 Recombinant avian adenovirus vector
10/27/1994	WO1994024267A1 Methods and materials for treatment of individuals infected with intracellular infectious agents
10/27/1994	WO1994024263A1 Needleless syringe using supersonic gas flow for particle delivery
10/27/1994	WO1994024168A1 Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof
10/27/1994	WO1994024163A2 Bispecific antigen-binding molecules
10/27/1994	WO1994024161A1 Novel receptor-type phosphotyrosine phosphatase-kappa
10/27/1994	WO1994024155A1 The therapeutic use of clostridium difficile toxin a
10/27/1994	WO1994023767A1 Oral drug delivery compositions and methods
10/27/1994	WO1994023759A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	WO1994023746A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
10/27/1994	WO1994023745A1 35/31 kda subunit of the entamoeba histolytica adherence lectin
10/27/1994	WO1994023744A1 Recombinant cytomegalovirus vaccine
10/27/1994	WO1994023734A1 Method of treatment of diseases by deletion of t cells
10/27/1994	WO1994023728A1 Immunogenic cancer proteins and peptides and method of use
10/27/1994	WO1994016068A3 Allergenic proteins and peptides from dog dander and uses therefor
10/27/1994	CA2161229A1 Novel receptor-type phosphotyrosine phosphatase-kappa
10/27/1994	CA2161109A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	CA2161095A1 Methods and materials for treatment of individuals infected with intracellular infectious agents
10/27/1994	CA2160983A1 Immunonanoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof
10/27/1994	CA2160713A1 Immunogenic cancer proteins and peptides and method of use
10/27/1994	CA2160583A1 Recombinant cytomegalovirus vaccine
10/27/1994	CA2160224A1 Bispecific antigen-binding molecules
10/27/1994	CA2160155A1 Model for gonococcal infection
10/27/1994	CA2159891A1 Method of treatment of diseases by deletion of t cells
10/27/1994	CA2157599A1 35/31 kda subunit of the entamoeba histolytica adherence lectin
10/26/1994	EP0621341A2 Monoclonal antibodies to bovine cytokines
10/26/1994	EP0621339A2 Immunogenic human influenza A virus haemagglutinin polypeptides
10/26/1994	EP0620860A1 Preparation of recombinant borrelia proteins
10/26/1994	EP0620850A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines
10/26/1994	EP0620827A1 Process for producing native,intravenously administrable stabilised immunoglobin
10/26/1994	EP0620742A1 Inactivation of cytotoxic drugs
10/26/1994	EP0620741A1 Cytotoxic drug therapy
10/26/1994	EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
10/26/1994	EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides
10/26/1994	CN1094093A Progenitor B cell stinulating factor
10/26/1994	CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
10/26/1994	CN1094061A Simultaneous determination of HbALc and haemoglobin variants with a glycation analogeous to HbALc
10/26/1994	CN1093927A Immunogenic composite pharmaceutics and its preparation method
10/25/1994	US5359046 Chimeric chains for receptor-associated signal transduction pathways
10/25/1994	US5359029 Having an amine and a carboxy end group(or substituent) which improve binding or immunogenic or antigenic activity and do not change its immunoreactivity
10/25/1994	US5358960 Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles
10/25/1994	US5358868 Strain of Bordetella; production of vaccine
10/25/1994	US5358866 Using cytosine deaminase as marker
10/25/1994	US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection
10/25/1994	US5358849 Hybridomas; culture products; radioisotope labelling; cancer screening
10/25/1994	US5358710 Administering an immunosuppressant amount of a tolerogenic conjugate of an antigenic polypeptide covalently bound to a water soluble polymer
10/25/1994	US5358649 Diagnosis for porcine malignant hyperthermia
10/23/1994	CA2121096A1 Monoclonal antibodies to bovine cytokines
10/21/1994	CA2116261A1 Epitopic regions of pneumococcal surface protein a
10/19/1994	EP0620277A1 Nucleic acid pharmaceuticals
10/19/1994	EP0620276A1 Humanised antibodies
10/19/1994	EP0620011A1 Antibody-drug conjugates
10/19/1994	EP0620010A1 HIV related peptides
10/19/1994	EP0620009A1 HIV related peptides
10/19/1994	EP0619841A1 T-cadherin adhesion molecule
10/19/1994	EP0619840A1 Pseudorabies virus vaccine
10/19/1994	EP0619839A1 Novel polypeptides for promoting cell attachment
10/19/1994	EP0619742A1 Transfection of lung via aerosolized transgene delivery
10/19/1994	EP0619741A1 Polar lipid composition of plant origin
10/19/1994	EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
10/19/1994	EP0489033B1 Bovine coronavirus polypeptides and vaccines
10/19/1994	CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
10/18/1994	US5356895 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins
10/18/1994	US5356797 Membrane expression of heterologous genes
10/18/1994	US5356713 Magnetizable composite microspheres of hydrophobic crosslinked polymer, process for preparing them and their application in biology
10/18/1994	US5356622 Homogenizing and sonicating flea midgut, separating and recovering
10/13/1994	WO1994023059A2 Anti-microbial agents and screening method therefor
10/13/1994	WO1994023037A1 Pharmaceuticals based on papillomaviruses
10/13/1994	WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II
10/13/1994	WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994	WO1994023019A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
10/13/1994	WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994	WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
10/13/1994	WO1994023014A1 Tumoricide t lymphocytes
10/13/1994	WO1994022917A1 Cross-reactive influenza a immunization
10/13/1994	WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	WO1994022913A1 Antigenic polypeptides of t. ovis and vaccines containing such polypeptides
10/13/1994	WO1994022912A1 Antigenic polypeptides of t. ovis and vaccines containing such polypeptides
10/13/1994	WO1994022479A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them
10/13/1994	WO1994022477A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
10/13/1994	WO1994022476A1 Multicomponent clostridial vaccines using saponin adjuvants
10/13/1994	WO1994022475A1 Cloned leptospira outer membrane protein
10/13/1994	WO1994022474A1 Method for treating kawasaki syndrome via immune modulation
10/13/1994	WO1994022473A1 Use of interleukin 7 to improve vaccine potency
10/13/1994	WO1994022472A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
10/13/1994	WO1994022462A1 Anti-aids immunomodulator complex
10/13/1994	WO1994022459A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic
10/13/1994	WO1994022443A1 Method for treating kawasaki syndrome
10/13/1994	WO1994021240A3 Superparamagnetic particles, process for producing the same and their use

1 ... 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 ... 1823